Peer Review History
| Original SubmissionApril 13, 2025 |
|---|
|
Dear Dr. Xie, Please submit your revised manuscript by Sep 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Onome Bright Oghenetega, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.-->--> -->-->3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.-->--> -->-->4. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.-->--> -->-->We require you to either present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or remove the figures from your submission:-->--> -->-->a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. -->--> -->-->We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:-->-->“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”-->--> -->-->Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.-->--> -->-->In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”-->--> -->-->b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.-->-->The following resources for replacing copyrighted map figures may be helpful:-->--> -->-->USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/-->-->The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/-->-->Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html-->-->NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/-->-->Landsat: http://landsat.visibleearth.nasa.gov/-->-->USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#-->-->Natural Earth (public domain): http://www.naturalearthdata.com/-->--> -->-->5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.-->--> -->-->6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. ?> Additional Editor Comments: Reviewers commend the study but request clearer model assumptions and sensitivity analyses for LMIC data, fuller explanation of GBD exposure attribution, discussion of co-exposure confounding, mechanistic insight into the SDI-disease burden pattern, control of smoking confounding, and rationale for sex differences. They also urge stronger policy and intervention recommendations, especially for low- and middle-SDI regions. These revisions will improve clarity and relevance. Reviewers' comments: Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1. The assumptions for the model may be clearly delineated in the methods. Also, the quality of the data from LMICs may be poor, hence sensitivity analyses may be conducted to unravel effect of the assumptions made 2. The manuscript would benefit from more detail on the methodology used by GBD to assign causality between occupational PAH exposure and TBL cancer. 3. Consider briefly discussing confounding by other occupational exposures (e.g., asbestos, silica), which are common co-exposures and may overlap in industrial settings. 4. The finding of an inverted U-shaped relationship between SDI and disease burden is interesting but underexplored. The authors should provide greater mechanistic or contextual explanation—e.g., linking it to patterns in industrialization, occupational regulation, and latency of cancer onset. 5.The paper would benefit from a stronger policy or practical intervention focus, especially in the conclusion. For example, what are the implications for workplace safety standards, surveillance, or global occupational health policy? Reviewer #2: This study provides a timely and comprehensive analysis of the global burden of tracheal, bronchus, and lung (TBL) cancer attributable to occupational polycyclic aromatic hydrocarbon (PAH) exposure, highlighting disparities across socio-demographic index (SDI) regions from 1990 to 2021. Its strengths include rigorous use of Global Burden of Disease (GBD) data, detailed age-period-cohort analyses, and insightful stratification by SDI, revealing concerning trends in low- and middle-income regions. However, limitations such as reliance on modeled estimates, potential confounding by smoking, and lack of occupational exposure details (e.g., duration, industry-specific risks) warrant clarification. The findings underscore the need for targeted workplace interventions but would benefit from deeper discussion on mechanistic pathways and policy implications to strengthen impact. Overall, the study advances understanding of occupational cancer disparities but requires minor methodological refinements and expanded contextualization for broader relevance. The study relies on GBD estimates. Could you elaborate on how occupational PAH exposure was specifically measured and attributed to TBL cancer cases in the GBD data? What validation exists for these exposure estimates? The APC analysis is interesting but complex. Could you provide more details on how the age, period, and cohort effects were separated, and what assumptions were made in this modeling? You note higher EAPCs in females compared to males globally. What might explain this gender difference, given that occupational PAH exposure has traditionally been higher in male-dominated industries? The inverted U-shaped relationship between SDI and TBL cancer burden is intriguing. Could you discuss potential mechanisms behind why middle SDI regions show the highest burden? The manuscript acknowledges uncertainties in GBD estimates. How might underreporting of occupational exposures in low/middle SDI regions affect your findings? Smoking is a major confounder for lung cancer. How was smoking controlled for in the attribution of TBL cancer to occupational PAH exposure? Given your findings, what specific interventions would you recommend for low/middle SDI regions to reduce occupational PAH exposure? How might your results inform international occupational health standards for PAH exposure limits? Have you considered analyzing specific high-risk occupations (e.g., asphalt workers, coke oven workers) where PAH exposure is particularly high? Were you able to examine dose-response relationships given the available data? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Xie, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 09 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Igor Burstyn Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Partly Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #3: Major: 1. Over-reliance on GBD Modelling and Data Limitations: While the authors have expanded the limitations section, the core issue remains that the study's findings are entirely dependent on the GBD's modelled estimates. The acknowledgement of incomplete and heterogeneous data from Low- and Middle-Income Countries (LMICs) is appropriate. However, the statement that findings for lower SDI regions are "conservative estimates" is speculative. The direction of bias (underestimation vs. overestimation) is difficult to ascertain due to competing factors: underreporting of occupational exposures and cancer cases versus potential over-attribution of TBL cancer to PAHs in the absence of robust confounder control at the individual level. This fundamental uncertainty should be more prominently and forcefully stated in the Abstract, Results, and Discussion, framing the entire interpretation of SDI disparities. A sensitivity analysis, though ideal, may not be feasible; therefore, the discussion of this limitation must be exceptionally strong. 2. Superficial Exploration of Gender Differences: The explanation for higher Estimated Annual Percentage Change (EAPC) in females, while improved, leans heavily on biological susceptibility. This requires more critical balance. The authors should delve deeper into potential socio-occupational factors: Segregation within industries: Are women increasingly entering specific roles within high-PAH industries that might have different exposure profiles (e.g., administrative roles in manufacturing vs. direct labor)? Informal sector work: In many LMICs, women are disproportionately represented in informal waste management or small-scale industries where PAH exposure is unmeasured and unregulated. Could this contribute to the trend? Interaction with other risk factors: The discussion should explicitly consider if trends in female smoking (which vary dramatically by region) could interact with or confound the observed PAH-attributable burden trends. The GBD's adjustment method is described, but its effectiveness in disentangling these correlated risks at the population level warrants a more cautious tone. 3. Mechanistic Explanation of the SDI-Burden Relationship: The added discussion on the inverted U-shaped curve is helpful but still somewhat descriptive. To strengthen the mechanistic insight: Link to Economic Transition Theories: Frame the findings within established theories of epidemiological or risk transition. The peak burden in middle-SDI regions mirrors patterns seen with other occupational and environmental hazards, where industrialization outpaces regulatory capacity and health infrastructure. Latency and Temporal Misalignment: Emphasize that the current burden in high-SDI regions reflects historical exposures from decades past (when their SDI was middle-range). Conversely, the current high burden in middle-SDI regions is a "real-time" consequence of present-day exposures. This temporal disconnect between exposure (past/present) and outcome (present/future) is crucial for interpreting the APC results and forecasting future burdens. The discussion should more explicitly connect the period/cohort effects to these historical industrialization waves. 4. Policy Recommendations Lack Specificity and Feasibility Analysis: The policy section remains generic. To enhance impact, recommendations should be more targeted and actionable: Beyond PPE and Limits: While important, recommending "stricter exposure limits and PPE" in low-resource settings is often infeasible without parallel investments in enforcement, monitoring, and worker education. Suggest concrete, incremental steps (e.g., prioritizing exposure control in 2-3 key industries, promoting simple ventilation improvements, developing low-cost exposure biomarkers for surveillance). Leveraging Existing Frameworks: Mentioning ILO conventions is good. Specify which conventions (e.g., C139, C155, C170) are most relevant and propose a tangible pathway for their adoption and monitoring in target regions. Case Examples: Briefly reference a successful intervention from a specific country (e.g., reduction in PAH exposures in a particular industry in a high-SDI setting) and discuss its potential for adaptation. Research-to-Policy Pipeline: Recommend establishing linked occupational cancer registries in sentinel middle-SDI industrial zones to improve data quality and directly inform local policy, moving beyond reliance on global models. Minor: 1. APC Analysis Interpretation: The interpretation of cohort effects ("recent generations might have lower death rates") is challenging given the 30-year study window and the long latency of TBL cancer. The observed cohort effect likely reflects exposures from the mid-20th century onwards. This complexity should be acknowledged to avoid oversimplification. 2. Figure and Table Presentation: Table 1: The table is dense. Consider creating a separate, simplified summary table for the main global and SDI-region results in the main text and moving the full sex-stratified table to the supplement. Figure 1 (Maps): Ensure the color scales are perfectly intuitive and include a clear note in the caption that the maps depict EAPC, not absolute burden. 3. Language and Flow: The manuscript is generally well-written. A final careful edit for concise phrasing and to avoid minor repetitions (e.g., the GBD methodology is described in very similar terms in multiple sections) would enhance readability. Reviewer #4: Thank you for the opportunity to review your work and I hope you find my comments of assistance. The manuscript addresses an important topic TBL cancer which has an increasing incidence, The attribution to preventable causes such as work is important. The striking finding for me is the sex differences which show a change in the direction of the usually expected ratios for occupational diseases. These changes in EAPC appear to be marked by country. Noting that the GBD methods for confounders were applied to what extent do the authors feel smoking rates in females may be contributory in comparison to those of males? The paper Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study Jani, Chinmay T. et al. ClinicalMedicine, Volume 79, 103033 may be helpful although it only examines a limited number of countries. However it is noted, "Among males, tobacco-associated ASMR fell over time across all countries, excluding China, Indonesia, and Pakistan. Among females, the reverse pattern was observed with overall increasing rates of tobacco-associated ASMR in most countries, with only rates in the USA and Mexico falling between 1990 and 2019". In addition to the above to what extent is proportional mortality playing a role in survival to die of TBL? L169 "While occupational exposure primarily occurs during working-age years (typically 15–75 years), the disease burden manifests later in life due to the long latency period of TBL cancer." Figure 3 demonstrates that actually the majority of deaths occur <75 years age. It is perhaps more useful to state the typical latency of TBL cancer. L49 "Increasing studies have reported disparities in incidence...", suggest "An increasing number of studies have reported disparities in incidence ..." L55 "PAHs are known carcinogens to increase the risk of TBL cancer" suggest "PAHs are carcinogens known to increase the risk of TBL cancer" L64 "PAH exposure, a significant while overlooked risk factor" suggest "PAH exposure, a significant although overlooked risk factor" L446 "subjected to relatively incomplete and heterogeneous data from LMICs." suggest "subject to relatively incomplete and heterogeneous data from LMICs." Figure 5 is interesting but particularly difficult to distinguish the markers for "Both" and "Female" even when I zoom ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Global burden and trends of tracheal, bronchus, and lung cancer attributed to occupational exposure to polycyclic aromatic hydrocarbons in regions with different sociodemographic index, 1990-2021 PONE-D-25-19840R2 Dear Dr. Xie, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Igor Burstyn Academic Editor PLOS One Additional Editor Comments (optional): Thank you for undertaking revisions. Hopefully you have better appreciation now of the limited utility of GBD data. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-19840R2 PLOS One Dear Dr. Xie, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Igor Burstyn %CORR_ED_EDITOR_ROLE% PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .